14:28 EST Dyne Therapeutics trading halted, volatility trading pause
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on DYN:
- Dyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
- Dyne Therapeutics price target lowered to $27 from $29 at Piper Sandler
- Dyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Dyne Therapeutics 17.15M share Spot Secondary priced at $17.50
- Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock